TRAMUNDIN retard 150mg price in UAE

Overview

Welcome to Dwaey, specifically on TRAMUNDIN retard 150mg Tablets/Modified Release page.
This medicine contains an important and useful components, as it consists of Tramadol HCl.
TRAMUNDIN retard 150mg is available in the market in concentration 150mg/Tablet and in the form of Tablets/Modified Release.

MUNDIPHARMA GmbH is the producer of TRAMUNDIN retard 150mg and it is imported from GERMANY, The most popular alternatives of TRAMUNDIN retard 150mg are listed downward .

Mode Of Action

Tramadol inhibits reuptake of norepinephrine, serotonin and enhances serotonin release. It alters perception and response to pain by binding to mu-opiate receptors in the CNS.

Indication

Moderate to severe pain
Postoperative pain

Precaution

Patients who suffer from emotional disturbance or depression, history of epilepsy or risk of seizure, head injury, increased intracranial pressure. Renal and hepatic impairment. Elderly. Pregnancy and lactation. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor pain relief, resp rate, BP, pulse rate; signs of tolerance, abuse, or suicidal ideation. Lactation: Drug excreted at high concentration in breast milk; not recommended

Side Effects

>10% Constipation (24-46%)
Nausea (24-40%)
Dizziness (10-33%)
Vertigo (26-33%)
Headache (18-32%)
Somnolence (7-25%)
Vomiting (9-17%)
Agitation (7-14%)
Anxiety (7-14%)
Emotional lability (7-14%)
Euphoria (7-14%)
Hallucinations (7-14%)
Nervousness (7-14%)
Spasticity (7-14%)
Dyspepsia (5-13%)
Asthenia (6-12%)
Pruritus (8-11%) 1-10% Diarrhea (5-10%)
Dry mouth (5-10%)
Sweating (6-9%)
Hypertonia (1-5%)
Malaise (1-5%)
Menopausal symptoms (1-5%)
Rash (1-5%)
Urinary frequency (1-5%)
Urinary retention (1-5%)
Vasodilation (1-5%)
Visual disturbance (1-5%) <1% Abnormal gait
Amnesia
Cognitive dysfunction
Depression
Difficulty in concentration
Dysphoria
Dysuria
Fatigue
Hallucinations
Menstrual disorder
Motor system weakness
Orthostatic hypotension
Paresthesia
Seizures
Suicidal tendencies
Syncope
Tachycardia
Tremor Frequency Not Defined Abnormal electrocardiogram (ECG)
Angioedema
Bronchospasm
Flushing
Hypertension
Hypotension
Myocardial ischemia
Palpitation
Urticaria
Withdrawal syndrome Potentially Fatal: Respiratory depression.

Contra indication

Suicidal patients, acute alcoholism; head injuries; raised intracranial pressure; severe renal impairment; lactation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Increased risk of convulsions or serotonin syndrome w/ SSRI, serotonin-norepinephrine reuptake inhibitors (SNRI), TCA and other seizure threshold lowering drugs (e.g. bupropion, mirtazapine, tetrahydrocannabinol). Decreased serum concentrations w/ carbamazepine. May potentiate the anti-depressant effect of norepinephrine, 5-HT agonists or lithium. Increased INR and ecchymoses w/ coumarin derivatives (e.g. warfarin). Potentially Fatal: Increased risk of seizure and serotonin syndrome w/ MAOIs.